Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,589Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Actavis Group PTC ehf

02 8Anpharm Przedsiebiorstwo Farmaceutyczne S.A.

03 2Anpharm Przedsiebiorstwo Farmaceutyczne Sa

04 1Aurovitas Spain, Sau

05 4Denk Pharma GmbH & Co. KG

06 4Doc Generici Srl

07 2Glenmark Arzneimittel Gmbh

08 6Krka Dd Novo Mesto

09 2Krka, D.D., Novo Mesto

10 3Les Laboratoires Servier

11 3Les Servier Laboratories

12 5Nobel Ilac Sanayii Ve Ticaret A.S.

13 2Sandoz Pharmaceuticals Sa

14 1Sandoz Pharmaceuticals d.d.

15 4Stada Pharmaceuticals Ag

16 2Stada Sl Laboratory

17 1Sun Pharmaceutical Industries (Europe) Bv

18 3Tad Pharma Gmbh

19 5Tecnimede Spain Pharmaceutical Industry Sa

20 1Teva Pharma Slu

21 2Viatris Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Indapamide; Perindopril Terc-Butylamine

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 4MG; 1.25 MG

Packaging :

Approval Date : 10-10-2023

Application Number : OGYI-T-6831-01IP2

Regulatory Info : Authorized

Registration Country : Spain

blank

02

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Indapamide; Perindopril Terc-Butylamine

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 4MG; 1.25 MG

Packaging :

Approval Date : 26-07-2024

Application Number : OGYI-T-6831-01IP3

Regulatory Info : Authorized

Registration Country : Spain

blank

03

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Indapamida; Perindopril Erbumina

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 4MG; 1.25 MG

Packaging :

Approval Date : 15-12-2021

Application Number : OGYI-T-6831-01IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

04

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Indapamida; Perindopril Erbumina

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 8MG; 2.5 MG

Packaging :

Approval Date : 27-10-2023

Application Number : OGYI-T-6831-02IP2

Regulatory Info : Authorized

Registration Country : Spain

blank

05

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Indapamida; Perindopril Erbumina

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 8MG; 2.5 MG

Packaging :

Approval Date : 16-04-2020

Application Number : OGYI-T-6831-02

Regulatory Info : Authorized

Registration Country : Spain

blank

06

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Indapamida; Perindopril Erbumina

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 8MG; 2.5 MG

Packaging :

Approval Date : 24-10-2022

Application Number : OGYI-T-6831-02IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

07

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Indapamida; Perindopril Erbumina

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 4MG; 1.25 MG

Packaging :

Approval Date : 03-04-2020

Application Number : OGYI-T-6831-01

Regulatory Info : Authorized

Registration Country : Spain

blank

08

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Indapamida; Perindopril Erbumina

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 8MG; 2.5 MG

Packaging :

Approval Date : 15-12-2021

Application Number : OGYI-T-6831-02IP

Regulatory Info : Authorized

Registration Country : Spain

blank

09

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Perindopril Tert-Butylamine Salt; Indapamide

Brand Name : Percanil Indapamide

Dosage Form : Tablet

Dosage Strength : 4MG; 1.25MG

Packaging :

Approval Date : 2016-01-29

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

blank

10

Anpharm Przedsiebiorstwo Farmaceutyczne ...

Country
ASPEN
Not Confirmed
arrow

Anpharm Przedsiebiorstwo Farmaceutyczne ...

Country
arrow
ASPEN
Not Confirmed

Indapamide; Perindopril Erbumin

Brand Name : Bipreterax

Dosage Form : Tablet

Dosage Strength : 8MG;2.5MG

Packaging :

Approval Date : 09-09-2025

Application Number : OGYI-T-6831-02IP3

Regulatory Info : Authorized

Registration Country : Spain

blank